Design and synthesis of thiazol derivatives with biological evaluations as antitumor agents
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | El-Sharkawy K.A. | |
dc.contributor.author | El-Brrati M.M.A. | |
dc.contributor.author | Ghardaly I.A. | |
dc.contributor.author | Ali M. | |
dc.contributor.other | Mohareb, R.M., Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt; Abdo, N.Y.M., Chemistry Department, Faculty of Education, Alexandria University, Alexandria, 21526, Egypt; El-Sharkawy, K.A., Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, P.O. Box 114, Jazan, 45142, Saudi Arabia, Department of Chemistry, Faculty of Biotechnology, October University for Modern Sciences and Arts (MSA), El-Wahat Road, 6th October City, Cairo, Egypt | |
dc.date.accessioned | 2020-01-09T20:40:23Z | |
dc.date.available | 2020-01-09T20:40:23Z | |
dc.date.issued | 2015 | |
dc.description.abstract | Background: Among the wide range of heterocycles, tetrahydrobenzothienopyridine derivatives acquired a special attention due to their wide range of pharmacological activities especially the therapeutic activities. Many pharmacological drugs containing the thiophene nucleus were known in the market. Method: A series of tetrahydrobenzothienopyridine derivatives were synthesized from the reaction of 2-amino- 3-benzoyl-4,5-dihydrobenzo[b]thiophen-6(7H)-one, synthesized and used for further heterocyclization reactions through reaction with different reagents. Results: Antiproliferative evaluations and c-Met kinase, Pim-1 kinase inhibitions were performed where some compounds revealed high activities. Conclusion: The inhibition of the newly synthesized compounds towards c-Met kinase, the five c-Metdependent cancer cell lines (A549, HT-29, MKN-45, U87MG, and SMMC-7721) and one c-Met-independent cancer cell line (H460) were investigated using foretinib as a standard drug. The results showed that compounds 6b, 7e, 9b, 9e, 16c and 20d were more active than foretinib. Furthermore, compounds 6b, 13b, 16b and 16c were selected to examine their Pim-1 kinase inhibition activity, where compounds 16b and 16c were of high potencies with IC50 values of 0.28 and 0.32 ?M, while compounds 6b and 13b were less effective (IC50 > 10 ?M). � 2018 Bentham Science Publishers. | en_US |
dc.identifier.doi | https://doi.org/10.5958/0974-360X.2015.00087.6 | |
dc.identifier.issn | 18715206 | |
dc.identifier.other | https://doi.org/10.5958/0974-360X.2015.00087.6 | |
dc.identifier.uri | https://t.ly/1VV9M | |
dc.language.iso | en_US | en_US |
dc.publisher | Bentham Science Publishers B.V. | en_US |
dc.relation.ispartofseries | Research Journal of Pharmacy and Technology | |
dc.relation.ispartofseries | 8 | |
dc.subject | October University for Modern Sciences and Arts | |
dc.subject | جامعة أكتوبر للعلوم الحديثة والآداب | |
dc.subject | University of Modern Sciences and Arts | |
dc.subject | MSA University | |
dc.subject | Kinase inhibitor | en_US |
dc.subject | Pyran | en_US |
dc.subject | Pyridine | en_US |
dc.subject | Thiazole | en_US |
dc.subject | Thienopyridine | en_US |
dc.subject | Thiophene | en_US |
dc.subject | 2 amino 3 benzoyl 4 5 dihydrobenzo[b]thiophen 6(7h) one | en_US |
dc.subject | 2 amino 7 oxo 4 phenyl 5 6 7 8 tetrahydrobenzo[4 5]thieno[2 3b]pyridine 3 carbonitrile | en_US |
dc.subject | 2 amino 7 oxo 4 phenyl 8 (2 phenylhydrazono) 5 6 7 8 tetrahydrobenzo[4 5]thieno[2 3 b]pyridine 3 carbonitrile | en_US |
dc.subject | 2 amino 7 oxo 4 phenyl 8 2 amino 8 (2 (4 chlorophenyl)hydrazono) 7 oxo 4 phenyl 5 67 8 tetrahydrobenzo [4 5]thieno[2 3 b]pyridine 3 carbonitrile | en_US |
dc.subject | 2 amino 8 (2 (4 methoxyphenyl)hydrazono) 7 oxo 4 phenyl 5 6 7 8 tetrahydrobenzo [4 5]thieno[2 3 b]pyridine 3 carbonitrile | en_US |
dc.subject | 2 hydroxy 7 oxo 4 phenyl 5 6 7 8 tetrahydrobenzo[4 5]thieno[2 3 b]pyridine 3 carbonitrile | en_US |
dc.subject | 2 hydroxy 7 oxo 4 phenyl 8 (2 phenylhydrazono) 5 6 7 8 tetrahydrobenzo[4 5]thieno[2 3 b]pyridine 3 carbonitrile | en_US |
dc.subject | 2 hydroxy 8 (2 (4 methoxyphenyl)hydrazono) 7 oxo 4 phenyl 5 6 7 8 tetrahydrobenzo[4 5]thieno[2 3 b]pyridine 3 carbonitrile | en_US |
dc.subject | 3 9 diamino 1 (4 bromophenyl) 7 phenyl 1 4 5 6 tetrahydropyrido[3 2 :4 5]thieno[2 3 f]quinoline 2 8 dicarbonitrile | en_US |
dc.subject | 3 9 diamino 1 (4 bromophenyl) 7 phenyl 5 6 dihydro 1hchromeno[6 5 :4 5]thieno[2 3 b]pyridine 2 8 dicarbonitrile | en_US |
dc.subject | 3 9 diamino 1 (4 chlorophenyl) 7 phenyl 1 4 5 6 tetrahydropyrido[3 2 :4 5]thieno[2 3 f]quinoline 2 8 dicarbonitrile | en_US |
dc.subject | 3 9 diamino 1 (4 chlorophenyl) 7 phenyl 5 6 dihydro 1hchromeno[6 5 :4 5]thieno[2 3 b]pyridine 2 8 dicarbonitrile | en_US |
dc.subject | 3 9 diamino 1 7 diphenyl 1 4 5 6 tetrahydropyrido[3 2 :4 5]thieno[2 3 f]quinoline 2 8 dicarbonitrile | en_US |
dc.subject | 3 amino 1 (4 bromophenyl) 9 hydroxy 7 phenyl 5 6 dihydro 1hchromeno[6 5 :4 5] thieno[2 3 b]pyridine 2 8 dicarbonitrile | en_US |
dc.subject | 3 amino 1 (4 chlorophenyl) 9 hydroxy 7 phenyl 5 6 dihydro 1hchromeno[6 5 :4 5] thieno[2 3 b]pyridine 2 8 dicarbonitrile | en_US |
dc.subject | 3 amino 9 hydroxy 1 7 diphenyl 1 4 5 6 tetrahydropyrido[2 :4 5]thieno[2 3 f]quinoline 2 8 dicarbonitrile | en_US |
dc.subject | 3 amino 9 hydroxy 1 7 diphenyl 5 6 dihydro 1h chromeno[6 5 :4 5]thieno[2 3 b]pyridine 2 8 dicarbonitrile | en_US |
dc.subject | 5 6 7 8 tetrahydrobenzo[4 5]thieno[2 3 b]pyridine | en_US |
dc.subject | 5 6 dihydro 1h chromeno[6 5 :4 5]thieno[2 3 b]pyridine | en_US |
dc.subject | 8 (2 (4 chlorophenyl)hydrazono) 2 hydroxy 7 oxo 4 phenyl 5 6 7 8 tetrahydrobenzo [4 5]thieno[2 3 b]pyridine 3 carbonitrile | en_US |
dc.subject | 8 (2 2 hydroxy 8 (2 (4 methoxyphenyl)hydrazono) 7 oxo 4 phenyl 5 6 7 8 tetrahydrobenzo[4 5]thieno[2 3 b]pyridine 3 carbonitrile | en_US |
dc.subject | androgen receptor | en_US |
dc.subject | antineoplastic agent | en_US |
dc.subject | cclohexane 1 4 dione | en_US |
dc.subject | protein kinase Pim 1 | en_US |
dc.subject | protein tyrosine kinase | en_US |
dc.subject | scatter factor receptor | en_US |
dc.subject | tetrahydrobenzothienopyridine | en_US |
dc.subject | thienopyridine derivative | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | unindexed drug | en_US |
dc.subject | antineoplastic agent | en_US |
dc.subject | cyclohexanone derivative | en_US |
dc.subject | protein kinase inhibitor | en_US |
dc.subject | protein kinase Pim 1 | en_US |
dc.subject | pyridine derivative | en_US |
dc.subject | antineoplastic activity | en_US |
dc.subject | antiproliferative activity | en_US |
dc.subject | Article | en_US |
dc.subject | cancer cell line | en_US |
dc.subject | cell growth | en_US |
dc.subject | cell proliferation | en_US |
dc.subject | colon cancer | en_US |
dc.subject | controlled study | en_US |
dc.subject | drug synthesis | en_US |
dc.subject | elemental analysis | en_US |
dc.subject | enzyme activity | en_US |
dc.subject | enzyme substrate | en_US |
dc.subject | GI50 | en_US |
dc.subject | human | en_US |
dc.subject | human cell | en_US |
dc.subject | IC50 | en_US |
dc.subject | infrared spectroscopy | en_US |
dc.subject | lung cancer | en_US |
dc.subject | MTT assay | en_US |
dc.subject | non small cell lung cancer | en_US |
dc.subject | prostate cancer | en_US |
dc.subject | protein expression | en_US |
dc.subject | radiosensitivity | en_US |
dc.subject | stomach cancer | en_US |
dc.subject | antagonists and inhibitors | en_US |
dc.subject | chemical structure | en_US |
dc.subject | chemistry | en_US |
dc.subject | dose response | en_US |
dc.subject | drug effect | en_US |
dc.subject | drug screening | en_US |
dc.subject | metabolism | en_US |
dc.subject | structure activity relation | en_US |
dc.subject | synthesis | en_US |
dc.subject | tumor cell line | en_US |
dc.subject | Antineoplastic Agents | en_US |
dc.subject | Cell Line, Tumor | en_US |
dc.subject | Cell Proliferation | en_US |
dc.subject | Cyclohexanones | en_US |
dc.subject | Dose-Response Relationship, Drug | en_US |
dc.subject | Drug Screening Assays, Antitumor | en_US |
dc.subject | Humans | en_US |
dc.subject | Molecular Structure | en_US |
dc.subject | Protein Kinase Inhibitors | en_US |
dc.subject | Proto-Oncogene Proteins c-pim-1 | en_US |
dc.subject | Pyridines | en_US |
dc.subject | Structure-Activity Relationship | en_US |
dc.title | Design and synthesis of thiazol derivatives with biological evaluations as antitumor agents | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Sangshetti, J.N., Dharmadhikari, P.P., Chouthe, R.S., Fatema, B., Lad, V., Karande, V., Darandale, S.N., Shinde, D.B., Microwave assisted nano (ZnO-TiO2) catalyzed synthesis of some new 4,5,6,7-tetrahydro-6-((5-substitituted-1,3,4-oxadia-diazol-2-yl)methyl)thieno [2,3-c]pyridine as antimicrobial agents (2013) Bioorg. Med. Chem. Lett, 23, pp. 2250-2253; Challa, N.R., Mamidisetty, B., Ghanta, M.R., Padi, P.R., Synthesis and pharmacological evaluation of 5-[2?-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]4,5,6,7-tetrahydro-thieno [3,2-c] pyridine derivatives as platelet aggregation inhibitors (2014) J. Saudi Chem. Soc, 18, pp. 513-519; Yao, K., Zhao, M., Zhang, X., Wang, Y., Li, L., Zheng, M., Pen, S., A class of oral N-[(1S,3S)-1-methyl-1,2,3,4-tetrahydro-?-carboline-3-carbonyl]-N ?-(amino-acid-acyl)hydrazine: Discovery, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysis (2011) Eur. J. Med Chem, 46, pp. 3237-3249; Hiruyoki, K., Fumitoshi, A., Atsuhiro, S., Tomio, K., Teruhiko, I., Shigeyoshi, N., Yasunori, T., Tetrahydrothienopyridine Derivatives, Furo and Pyrrolo Analogs Thereof and Their Preparation and Uses for Inhibiting Blood Platelet Aggregation 1994, , US Patent 5288726; Srivastava, B.K., Solanki, M., Mishra, B., Soni, R., Jayadev, S., Valani, D., Jain, M., Patel, P.R., Synthesis and antibacterial activity of 4,5,6,7-tetrahydro-thieno 4, [3,2-c] pyridine quinolones (2007) Bioorg. Med. Chem, 17, pp. 1924-1929; Leung, E., Pilkington, L.I., Rensburg, M.V., Jeon, C.Y., Song, M., Arabshahi, H.J., Zoysa, G.H., Reynisson, J., Synthesis and cytotoxicity of thieno [2,3-b] quinoline-2-carboxamide & cycloalkyl [b]thieno [3,2-e] pyridine-2-carboxamide derivatives (2016) Bioorg. Med. Chem, 24, pp. 1142-1154; Liu, L.B., Siegmund, A., Xi, N., Kaplan-Lefko, P., Rex, K., Chen, A., Lin, J., Kim, T.S., Discovery of a Potent, Selective, and Orally Bioavailable c-Met Inhibitor: 1-(2-Hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinoline-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458) (2008) J. Med. Chem, 51, pp. 3688-3691; Peach, M.L., Tan, N., Tan, N., Choyke, S.J., Giubellino, A., Athauda, G., Burke, T.R., Bottaro, D.P., Directed discovery of agents targeting the met tyrosine kinase domain by virtual screening (2009) J. Med. Chem, 52, pp. 943-951; Knudsen, B.S., Gmyrek, G.A., Inra, J., Scherr, D.S., Vaughan, E.D., Nanus, D.M., Kattan, M.W., Woude, G.F., High expression of the Met receptor in prostate cancer metastasis to bone (2002) Urology, 60, pp. 1113-1117; Humphrey, P.A., Zhu, X., Zarnegar, R., Swanson, P.E., Ratliff, T.L., Vollmer, R.T., Day, M.L., Hepatocyte growth factor and its receptor (C-MET) in prostatic carcinoma (1995) Am. J. Pathol, 147, pp. 386-396; Verras, M., Lee, J., Xue, H., Li, T.H., Wang, Y., Sun, Z., The androgen receptor negatively regulates the expression of c-Met: Implications for a novel mechanism of prostate cancer progression (2007) Canc. Res, 67, pp. 967-975; Bacco, F.D., Luraghi, P., Medico, E., Reato, G., Girolami, F., Perera, T., Gabriele, P., Boccaccio, C., Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer (2011) J. Natl. Canc. Inst, 103, pp. 645-661; Zhu, W., Wang, W., Xu, S., Wang, J., Tang, Q., Wu, C., Zhao, Y., Zheng, P., Synthesis, and docking studies of phenylpyrimidinecarboxamide derivatives bearing 1H-pyrrolo [2,3-b] pyridine moiety as c-Met inhibitors (2016) Bioorg. Med. Chem, 24, pp. 1749-1756; Zhang, Z., Lee, J.C., Li, L., Olivas, V., Au, V., Laframboise, T., Abdel-Rahman, M., Bivona, T.G., Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer (2012) Nat. Genet, 44, pp. 852-860; Tiedt, R., Degenkolbe, E., Furet, P., Appleton, B.A., Wagner, S., Schoepfer, J., Buck, E., Hofmann, F.A., Drug resistance screen using a selective MET inhibitor reveals a spectrum of mutations that partially overlap with activating mutations found in cancer patients (2011) Canc. Res, 71, pp. 5255-5264; Takayuki, N., Osamu, T., Atsumi, Y., Tomohiro, M., Keiko, T., Setsuo, F., Shuji, S., Hiroshi, O., E7050: A dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models (2010) Canc. Sci, 101, pp. 210-215; Peach, M.L., Tan, N., Tan, N., Choyke, S.J., Giubellino, A., Athauda, G., Burke, T.R., Bottaro, D.P., Directed discovery of agents targeting the met tyrosine kinase domain by virtual screening (2009) J. Med. Chem, 52, pp. 943-951; Xu, X., Shi, W., Zhou, Y., Wang, Y., Zhang, M., Song, L., Deng, H., Convenient one-pot synthesis of monofluorinated functionalized 4-H-pyran derivatives via multi-component reactions (2015) J. Fluorine Chem, 176, pp. 127-133; Penta, S., Gadidasu, K.K., Basavoju, S., Rao, V.R., An efficient one-pot synthesis of pyrazolyl-[1,2,4]triazolo [3,4-b] [1,3,4] thiadiazin-6-yl)-2H-pyran-2-one derivatives via multicomponent approach and their potential antimicrobial and nematicidal activities (2013) Tetrahed. Lett, 54, pp. 5663-5666; Vereshchagin, A.N., Elinson, M.N., Ryzhkov, F.V., Nasybullin, R.F., Bobrovsky, S.I., Goloveshkin, A.S., Egorov, M.P., Multicomponent assembling of salicyl aldehydes, malononitrile, and 4-hydroxy-6-methyl-2H-pyran-2-one: A fast and efficient approach to medicinally relevant 2-amino-4H-chromene scaffold (2015) C.R. Chimie, 18, pp. 1344-1349; Hazeri, N., Maghsoodlou, M.T., Mir, F., Kangani, M.M., Saravani, H., Molashahi, E., An efficient one-pot three-component synthesis of tetrahydrobenzo [b]pyran and 3,4-dihydropyrano [c]chromene derivatives using starch solution as catalyst (2014) Chin. J Catal, 35, pp. 391-395; Wagh, Y.B., Tayade, Y.A., Padvi, S.A., Patil, B.S., Patil, N.B., Dalal, D.S., A cesium fluoride promoted efficient and rapid multicomponent synthesis of functionalized 2-amino-3-cyano-4Hpyran and spirooxindole derivatives (2015) Chin. Chem. Lett, 26, pp. 1273-1277; Jolodar, O.G., Shirini, F., Seddighi, M., Introduction of a novel basic ionic liquid containing dual basic functional groups for the efficient synthesis of spiro-4H-pyrans (2016) J. Mol. Liq, 224, pp. 1092-1111; Zakeri, M., Nasef, M.M., Lotf, E.A., Moharami, A., Heravi, M.M., Sustainable alternative protocols for the multicomponent synthesis of spiro-4H-pyrans catalyzed by 4-dimethylaminopyridine (2015) J. Induct. Engin. Chem, 29, pp. 273-281; Tabassum, S., Govindaraju, S., Khan, R.R., Pasha, M.A., Ultrasound mediated, iodine catalyzed green synthesis of novel 2-amino-3-cyano-4H-pyran derivatives (2015) Ultrasonic Sonochem, 24, pp. 1-7; El-Sayed, N.N.E., Abdelaziz, M.A., Wardakhan, W.W., Mohareb, R.M., The Knoevenagel reaction of cyanoacetylhydrazine with pregnenolone: Synthesis of thiophene, thieno [2,3-d] pyrimidine, 1,2,4-triazole, pyran and pyridine derivatives with anti-inflammatory and anti-ulcer activities (2016) Steroids, 107, pp. 98-111; Han, Y., Tang, W.Q., Yan, C.G., Gewald-type reaction of double activated 2,3-diarylcyclopropanes with elemental sulfur for synthesis of polysubstituted 2-aminothiophenes (2014) Tetrahed. Lett, 55, pp. 1441-1443; Puterov�, Z., Andicsov�, A., V�gh, D., Synthesis of ?-conjugated thiophenes starting from substituted 3-oxopropanenitriles via Gewald reaction (2008) Tetrahed, 64, pp. 11262-11269; David, M., Barnes, D.M., Anthony, R., Haight, A.R., Hameury, T., Maureen, A., McLaughlin, M.A., Toma, J.D.R., New conditions for the synthesis of thiophenes via the Knoevenagel/Gewald reaction sequence. Application to the synthesis of a multitargeted kinase inhibitor (2006) Tetrahed, 62, pp. 11311-11319; Helal, M.H., Salem, M.A., Gouda, M.A., Ahmed, N.S., El-Sherif, A.A., Design, synthesis, characterization, quantum-chemical calculations and anti-inflammatory activity of novel series of thiophene derivatives (2015) Mol. Biochem. Spectr, 147, pp. 73-83 | |
dcterms.source | Scopus |